Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
N. Chernyh (Moscow , Russian Federation), M. Tikhonova (Moscow , Russian Federation), V. Romanov (Moscow , Russian Federation), A. Polyakova (Moscow , Russian Federation). Effectiveness of mesodiencephalic modulation in treatment of XDR TB patients with concomitant type II diabetes mellitus. 3000

Member's Comments

No comment yet.

Related content which might interest you: Mesodiencephalic modulation in the treatment of XDR TB patients with concomitant type II diabetes mellitus Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 Treatment effectiveness among patients with newly detected pulmonary tuberculosis with diabetes mellitus comorbidity Source: Eur Respir J 2004; 24: Suppl. 48, 653s Year: 2004 Clinical manifestations and efficacy MDR/XDR tuberculosis in patients with different type’s of diabetes mellitus Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015 Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2? Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009 Efficacy of treatment of MDR/XDR TB patients with diabetes mellitus Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Effectiveness of lung surgery in MDR TB patients with diabetes mellitus Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016 Impact of diabetes mellitus on MDR-TB outcome Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018 Outcomes among patients with pulmonary TB with diabetes mellitus treated with anti-TB drugs of 1st line Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010 The evaluation of tuberculosis risk in diabetes mellitus patients in a high incidence of tuberculosis region Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010 Comparison of the clinical manifestations of tuberculosis in patients with different type’s of diabetes mellitus and without it Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016 Newly detected pulmonary tuberculosis in patients combined with diabetes mellitus and without it. Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Clinical features of pulmonary tuberculosis in patients with diabetes mellitus Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012 Prevalence and factors associated with diabetes mellitus among tuberculosis patients: a nationwide cohort Source: Eur Respir J 2016; 48: 264-268 Year: 2016 Impact of diabetes mellitus on pulmonary tuberculosis clinical presentation and treatment outcomes Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018 Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Intensive chemotherapy of pulmonary tuberculosis in patients with diabetes mellitus Source: Eur Respir J 2004; 24: Suppl. 48, 648s Year: 2004 Side effects of isoniazid and streptomycine in patients with pulmonary tuberculosis accompanying diabetes mellitus and diabetic foot syndrome Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III Year: 2008 New approaches to surgical treatment of patients with tuberculosis of lungs revealed for the first time in combination with diabetes mellitus Source: Annual Congress 2012 - Surgery for infections and congenital diseases Year: 2012 Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis in an endemic area Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013